Pharma Equity Group A/S
CSE:PEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Analyst IMS Investment Management Services Ltd
TASE:ANLT
|
IL |
Pharma Equity Group A/S
Total Current Liabilities
Pharma Equity Group A/S
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharma Equity Group A/S
CSE:PEG
|
Total Current Liabilities
kr8.8m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-1%
|
|
|
Jeudan A/S
CSE:JDAN
|
Total Current Liabilities
kr1.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
Copenhagen Capital A/S
CSE:CPHCAP ST
|
Total Current Liabilities
kr59.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
P
|
Prime Office A/S
CSE:PRIMOF
|
Total Current Liabilities
kr131.9m
|
CAGR 3-Years
21%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
|
Fast Ejendom Danmark A/S
CSE:FED
|
Total Current Liabilities
kr58.6m
|
CAGR 3-Years
22%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
E
|
EgnsINVEST Ejendomme Tyskland A/S
CSE:EGNETY
|
Total Current Liabilities
kr3.2m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-29%
|
|
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.
See Also
What is Pharma Equity Group A/S's Total Current Liabilities?
Total Current Liabilities
8.8m
DKK
Based on the financial report for Dec 31, 2025, Pharma Equity Group A/S's Total Current Liabilities amounts to 8.8m DKK.
What is Pharma Equity Group A/S's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
-1%
Over the last year, the Total Current Liabilities growth was 2%. The average annual Total Current Liabilities growth rates for Pharma Equity Group A/S have been -29% over the past three years , -18% over the past five years , and -1% over the past ten years .
